Skip to main content
2023 BMES Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Anandi Krishnan, PhD (she/her/hers)

Stanford University - School of Medicine
Palo Alto, California, United States

Anandi Krishnan is a translational scientist and principal investigator at Stanford University School of Medicine. Dr. Krishnan is in the process of transitioning to Rutgers University Department of Biomedical Engineering as tenure-track Associate Professor starting January 2024.

Dr. Krishnan’s current research focuses on transcriptional and epigenetic mechanisms of blood cell function and dysfunction in human disease. In particular, she is interested in expanding our understanding of the multifaceted function of blood platelets in cancer, inflammation, or immunity, beyond their classical role in hemostasis and thrombosis. Her work integrates omics-based discovery (from large clinical cohorts) with experimental and computational systems biology approaches toward a deeper understanding of disease mechanisms, risk stratification, and novel therapeutic strategies. Recent findings have outlined a number of heretofore unrecognized platelet mechanisms that are central to platelet response in disease.

Her interest in the field was primarily influenced by her experiences at the Duke Translational Research Institute, studying RNA-based aptamer-antidote molecules for antithrombotic therapy (laboratory of Drs. Bruce Sullenger, PhD and Richard Becker, MD) and her doctoral work at Penn State Biomedical Engineering (with Dr. Erwin Vogler, PhD) establishing the biophysical mechanisms of contact activation in blood coagulation. Funding for Anandi’s research includes her current NIH NHGRI genomic medicine career development award, MPN Research Foundation Challenge grant, multiple Stanford internal awards and NIH NCATS diversity/research re-entry award.

Presentation(s):

Email Anandi